| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |